glp-1 receptor agonist and dpp-4 inhibitor combination contraindicated Table 2 from DPP- 4 Inhibitors in the Management of Type 2 Diabetes Mellitus Mechanism of action for GIP,

While early-phase studies have demonstrated safety and some efficacy signals, larger randomized trials are necessary to validate their long-term effects, cost-effectiveness, and comparative utility (Rodrguez-Merchn, 2022

Triple agonists including retatrutide show exceptional promise based on remarkable weight loss and liver fat normalization in early trials, with dedicated MASH histology studies ongoing

Together, they create a metabolic environment where overeating becomes physiologically difficult rather than just psychologically challenging

this doesn't necessarily mean astaxanthin is better than CoQ10

- Favorece al crecimiento muscular

Key Benefits: Promotes skin brightening and reduces pigmentation